The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Lutinus 100 mg vaginal tablets

Ferring Ireland LtdPA1009/022/001

Main Information

Trade NameLutinus 100 mg vaginal tablets
Active SubstancesProgesterone
Dosage FormVaginal tablet
Licence HolderFerring Ireland Ltd
Licence NumberPA1009/022/001

Group Information

ATC CodeG03DA Pregnen (4) derivatives
G03DA04 progesterone


License statusAuthorised
Licence Issued05/02/2010
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back